Napsin A
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Napsin A, also napsin, is a commonly used immunostain in pulmonary pathology.
Positive
- Lung adenocarcinoma - 83% of cases.[1]
- Papillary renal cell carcinoma 79% of cases.[1]
- Renal oncocytoma 57% of cases.[2]
Occasionally positive
- Clear cell renal cell carcinoma - 34% of cases.[1]
- Papillary thyroid carcinoma - 2/81 cases, tall cell variant only.[1]
- Clear cell tubulopapillary RCC - 47% of cases.[2]
Negative
- Squamous cell carcinoma of the lung.[1]
- Colorectal adenocarcinoma.[1]
- Pancreatic adenocarcinoma.[1]
- Breast carcinoma (0 positive of 17 cases[1]).
Napsin in pulomonary adenocarcinoma (WC/Yale Rosen)
Coarse Napsin staining pattern (WC/Yale Rosen)
.jpg)
.jpg)
See also
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Bishop, JA.; Sharma, R.; Illei, PB. (Jan 2010). "Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.". Hum Pathol 41 (1): 20-5. doi:10.1016/j.humpath.2009.06.014. PMID 19740516.
- ↑ 2.0 2.1 Zhu, B.; Rohan, SM.; Lin, X. (Mar 2015). "Immunoexpression of napsin A in renal neoplasms.". Diagn Pathol 10: 4. doi:10.1186/s13000-015-0242-z. PMID 25889632.